Participant flow and recruitment
VIRUS
In this study, one hundred thirty-four (134) patients were screened. One hundred five (105) patients were enrolled and randomized in this study. Patients with undetectable virus levels in saliva at T0 were excluded from the final analysis study. Ninety-five (95) patients were included in the final analysis: 32 from the CPC+Zn group, 31 from the CPC group, and 32 from the negative control group (